Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)A Study of CCI-001 in Patients With Recurrent and/or Metastatic Solid Tumours
Phase 1
Recruiting
- Conditions
- Cancer: Recurrent and/or Metastatic Solid Tumours
- Interventions
- First Posted Date
- 2021-04-01
- Last Posted Date
- 2025-06-12
- Lead Sponsor
- PharmaMatrix Holdings Ltd
- Target Recruit Count
- 70
- Registration Number
- NCT04823897
- Locations
- 🇨🇦
Cross Cancer Institute, Edmonton, Alberta, Canada
News
No news found